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Abstract
Background: Streptococcus pneumoniae, a Gram-positive bacterium carried in the human nasopharynx, is an
important human pathogen causing mild diseases such as otitis media and sinusitis as well as severe diseases
including pneumonia, meningitis and sepsis. There is a strong resemblance between the anatomy, immunology
and physiology of the pig and human species. Furthermore, there are striking similarities between S. suis
pathogenesis in piglets and S. pneumoniae pathogenesis in humans. Therefore, we investigated the use of piglets
as a model for pneumococcal colonization and invasive disease.
Results: Intravenous inoculation of piglets with an invasive pneumococcal isolate led to bacteraemia during 5 days,
showing clear bacterial replication in the first two days. Bacteraemia was frequently associated with fever and septic
arthritis. Moreover, intranasal inoculation of piglets with a nasopharyngeal isolate led to colonization for at least six
consecutive days.
Conclusions: This demonstrates that central aspects of human pneumococcal infections can be modelled in
piglets enabling the use of this model for studies on colonization and transmission but also on development of
vaccines and host-directed therapies. Moreover this is the first example of an animal model inducing high levels of
pneumococcal septic arthritis.
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Background
Streptococcus pneumoniae is a Gram positive bacterium
carried in the nasopharynx and spread by human-to-
human transmission causing different diseases ranging
from mild, such as otitis media and sinusitis, to severe
diseases, including pneumonia, meningitis and sepsis [1, 2].
Furthermore, S. pneumoniae is an important cause of sep-
tic arthritis [3], and endocarditis [4]. Asymptomatic
colonization of the nasopharynx is an essential prere-
quisite for pneumococcal disease. Worldwide about 40-
90 % of children and 10 % of adults are colonized with S.
pneumoniae [5]. Risk groups for pneumococcal disease
are children under the age of 2 years, elderly people and
immunocompromised patients [1]. Morbidity and mortal-
ity caused by S. pneumoniae infections are high, both in
the developing and the developed world: annually 1.6 mil-
lion people die worldwide of pneumococcal infections [6].
Since pigs are very similar to humans in terms of anat-
omy, immunology and physiology [7] they might be a
good model to mimic human disease. More importantly,
the porcine immune system closely resembles that of the
human immune system for over 80 % of the analyzed
parameters, whereas for mice this is less than 10 % [8].
For example the porcine complement activation is simi-
lar to that of humans in all pathways [9] and pigs have
Th17 cells with functions similar to their human coun-
terparts [10]. Moreover, the cardiovascular physiology of
pigs and men are very similar, indicating that pig models
could be used to study the effects of S. pneumoniae on
the cardiovascular system. Pigs have been described as
suitable models for human infectious diseases of differ-
ent nature, like Gram-negative bacteria induced menin-
gitis [11] and pneumonia [12], Gram-positive bacteria
induced endocarditis [13], scabies infections [14] and
fungal infections [15]. Moreover, the availability of a
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large animal model allows to do repeated measurements,
for example colonization can be monitored in time with-
out killing the animal.
Piglets are the natural host for Streptococcus suis
infections. There are striking similarities between S. suis
pathogenesis in piglets and S. pneumoniae pathogenesis
in humans. Piglets develop severe disease like menin-
gitis, sepsis, arthritis, endocarditis or pneumonia upon
infection with S. suis [16]. S. suis is carried in the oro-
pharynx, the bacterium colonizes the tonsil of piglets,
similar to S. pneumoniae in children [17]. Furthermore,
genetically S. suis and S. pneumoniae are closely related
[18]. In this study, we investigate the use of piglets as a
model for human colonization and invasive disease
caused by S. pneumoniae. We demonstrate that the pig
is a suitable model to study pneumococcal colonization
and invasive disease that could potentially be used for
the development of new vaccines and therapies.
Results
Bacteraemia
PBCN0214 is a serotype 8 strain, which was isolated
from a patient with pneumonia, meningitis and sepsis
without underlying co-morbidities. The piglets were in-
oculated intravenously, in the vena jugularis, with a high
(n = 5) or a low dose (n = 5). All piglets, with the high
dose as well as with the low dose, developed bacteraemia
(Fig. 1a). Bacterial numbers increased during the first
two days, indicating that pneumococci replicated in the
blood. However, piglets inoculated with the low dose
cleared the bacteria faster and reached a significantly
lower number of colony forming units (CFU) in blood
than piglets inoculated with the high dose (p < 0.01)
(Fig. 1a). Interestingly, one of the intranasally inoculated
piglets developed pneumococcal bacteraemia as well,
clearly demonstrating that S. pneumoniae is able to
breach host defence barriers in pigs after intranasal
inoculation (Fig. 1b). Bacteria isolated from blood were
confirmed to be S. pneumoniae using Matrix-Assisted
Laser Desorption/Ionization–Time of Flight (MALDI-
TOF).
Oropharyngeal colonization
BHN418, a serotype 6B strain, has been frequently de-
scribed in an experimental human carriage model [19, 20].
This strain was originally isolated from a colonized indi-
vidual [21]. The piglets were inoculated intranasally with a
high (n = 5) or a low dose (n = 5). Because selective cultur-
ing of S. pneumoniae using gentamycin was not possible
in pigs due to overgrowth of many different organisms,
the pneumococcal colonization of the oropharyngeal cav-
ity was measured by polymerase chain reaction (PCR) on
tonsil swab samples. The data (Fig. 2) show that the piglets
inoculated intranasally with the highest dose, were colo-
nized with S. pneumoniae throughout the experiment.
Two piglets from this group were not (detectably) colo-
nized at the end of the experiment. The oropharynx of all
five piglets in this group was colonized for at least 5 days.
Piglets intranasally inoculated with the low dose showed
limited colonization. These data clearly showed that S.
pneumoniae can colonize the porcine oropharynx for at
least seven consecutive days. S. suis was also detected by
PCR on all days despite the specific selection of S. suis
negative piglets. This was also confirmed by MALDI-TOF
analyses.
Fever and pro-inflammatory cytokine responses
Immediately after inoculation an increase in body
temperature (p < 0.01) was observed in all piglets inocu-
lated with the high dose (intravenously as well as intra-
nasally) (Fig. 3a and b). Piglets inoculated intravenously
with a high dose were febrile from 6 h post-inoculation
(p.i.) until 4 days p.i. and showed a second fever peak at
6 days p.i. Piglets inoculated intravenously with a low
Fig. 1 Bacteraemia in piglets due inoculation with S. pneumoniae. Bacteraemia was monitored on a daily base in piglets infected intravenously
(Panel a) or intranasally (Panel b) with S. pneumoniae by plating EDTA blood on selective agar plates. Mean bacterial counts are depicted, error
bars represent standard error of the mean. Open symbols represent piglets infected with a low dose, closed symbols piglets infected with a high
dose. Each symbol represents 3 − 5 piglets, error bars show standard deviation. ** p < 0.01; *** p < 0.001 (ANOVA)
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dose were only febrile from 24 h p.i. until 2 days p.i., but
the temperature remained above pre-infection level for
5 days. The intranasally inoculated pigs displayed shorter
febrile periods: the high dose group was febrile after 6 h
p.i. until 2 days p.i., with a second peak at 5 days p.i.
whereas the low dose group was only febrile once at
5 days p.i. One day after inoculation, white blood cell
counts of the intravenously inoculated piglets increased
significantly (p < 0.01), compared to white blood cell
counts of the intranasally inoculated piglets, irrespective
of the inoculation dose used (Fig. 3c and d). This
leukocytosis is most likely the consequence of bacter-
aemia that was induced after intravenous inoculation.
Systemic pro-inflammatory immune responses were
monitored in both high dose groups of piglets. Intraven-
ously infected piglets showed a peak production of Inter-
leukin 6 (IL-6) and Interleukin 1 beta (IL-1-β) serum
concentrations 1 day post-infection (p <0.001) (Fig. 4a
and b) to decrease to normal levels respectively 3 and
5 days post-infection.
Fig. 2 Colonization of S. pneumoniae in the oropharynx of
intranasally inoculated piglets. Colonization with S. pneumoniae was
detected using a pneumococcal specific qPCR. At day 0 prior to
infection, no S. pneumoniae was detected. Open symbols represent
piglets infected with a low dose, closed symbols piglets infected
with a high dose. Each symbol represents 3 − 5 piglets, error bars
show standard deviation. * p < 0.05 (ANOVA). 100 pg of DNA is
equivalent to approximately 4 × 105 CFUs
Fig. 3 Body temperature and white blood cell counts of piglets infected with S. pneumoniae. Body temperature was recorded daily before
inoculation and three times a day after inoculation. Mean body temperature of piglets inoculated intravenously (Panel a) or intranasally
(Panel b) with S. pneumoniae are depicted. White blood cell counts were determined daily, mean counts are depicted for piglets inoculated
intravenously (Panel c) or intranasally (Panel d). Open symbols represent piglets inoculated with a low dose, closed symbols piglets inoculated
with a high dose. Each symbol represents 3 − 5 piglets, error bars show standard deviation. *** p < 0.001 (ANOVA)
de Greeff et al. BMC Microbiology  (2016) 16:102 Page 3 of 8
Arthritis
Four out of the five piglets inoculated intravenously with
a high dose and one piglet inoculated intravenously with
a low dose showed clinical signs of polyarthritis in sev-
eral legs for one or more consecutive days (Table 1).
Within 16 h after inoculation 4 piglets showed signs of
arthritis (lameness, swelling of joints) in 1–3 legs, in one
piglet arthritis in two joints was observed at 32 h post
inoculation. In three piglets arthritis was short-lasting
(less than 16 h); two piglets, both intravenously inocu-
lated with a high dose were euthanized at 1 and 4 days
post-infection as they reached the humane end points
due to either the severity of disease in one piglet or the
long duration of arthritis in another piglet. None of the
piglets showed signs of arthritis from 4 days after inocu-
lation on. Besides clinical manifestation of arthritis, no
other signs of illness were observed at the regular clin-
ical examination time points. However, immediately after
inoculation, in all groups independent of the administra-
tion route or the inoculation dose used, the playing
behaviour of piglets as measured by continuous record-
ing of the movement of a toy chain, was considerably re-
duced compared to the pre-infection period (Fig. 5).
These data clearly represent a discrete expression of sub-
clinical illness after inoculation. At the time of necropsy,
two piglets (one inoculated intravenously with a high
dose and one inoculated intranasally with a low dose)
showed signs of peritonitis with fibrinous exudates in
the peritoneal cavity. Similar clinical signs of disease are
frequently observed in piglets inoculated with S. suis,
clearly indicating that S. suis as well as S. pneumoniae
preferably cause infections at the serosae.
Pathology
During necropsy, five piglets inoculated intravenously (2
with the high dose and 3 with the low dose) as well as 2
piglets inoculated intranasally showed a serous hyperse-
cretion of synovial fluid. Bacteriological examination of
two joints with a serofibrinous arthritis revealed that the
arthritis was caused by S. pneumoniae. Histological
examination of the affected synovial membranes of the
joints with arthritis revealed a serofibrinous synovialitis
with moderate to extended mixed leucocyte cell infiltra-
tion into the subsynovial tissue in three piglets (Fig. 6b);
in joints with increased synovial fluids the histological
changes were characterized by few foci with perivascular
mononuclear inflammatory cells in the subsynovial tis-
sue (Fig. 6a). This strongly suggests that the clinical
symptoms, overfilled joints and arthritis indeed were
caused by a systemic pneumococcal infection. During
gross pathology mild, focal abnormalities in lungs were
observed in the intravenously inoculated low dose group
as well as in both groups of intranasally inoculated
piglets.
Fig. 4 Systemic pro-inflammatory immune responses in piglets infected with S. pneumoniae. Serum concentrations of IL-1-β (panel a) and IL-6
(panel b) were determined by ELISA for piglets inoculated intravenously with a high dose of S. pneumoniae (open circles, dotted line) or intranasally with a
high dose of S. pneumoniae (closed circles, solid line). Each symbol represents 3 – 5 piglets, error bars show standard deviation. *** p< 0.001 (ANOVA)
Table 1 Septic arthritis in piglets due to Streptococcus
pneumoniae
Inoculation route Maximum number of
joints affected
Number of days with 1






* Piglet was euthanized 1 day post-infection due to reaching humane
end points
** Piglet was euthanized 4 days post-infection due to reaching humane
end points
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Discussion
Here we demonstrate that pigs can be used as a model
for human S. pneumoniae infections. Induction of
pneumococcal bacteraemia results in persistent fever and
disease, mainly septic arthritis. Systemic pro-inflammatory
immune responses confirm the presence of pneumococcal
induced inflammation in piglets. Moreover, we showed
that S. pneumoniae is able to colonize the oropharyngeal
cavity of piglets, allowing for colonization and transmis-
sion studies.
Stable oropharyngeal colonization of piglets with S.
pneumoniae was determined by qPCR on tonsillar swab
samples. Selective culturing of S. pneumoniae using genta-
mycin was not possible in pigs due to overgrowth of many
different organisms, making it impossible to specifically
count pneumococcal CFU. Despite the complex micro-
biome of porcine tonsils, consisting of more than 100 spe-
cies [22, 23] including S. suis, it is apparently possible for
S. pneumoniae to find its niche leading to colonization for
at least 6 days. This enables the study of colonization as a
function of time. Currently, many research groups con-
centrate on the development of a universal serotype-
independent vaccine, based on pneumococcal proteins
[24]. There is a lot of experience with vaccination chal-
lenge experiments in pigs with porcine pathogens with a
similar pathogenesis as S. pneumoniae in humans, like S.
suis [25, 26]. The piglet model described here may be an
attractive alternative to study the efficacy of vaccine candi-
dates, in particular at the level of colonization.
A significant number of intravenously inoculated piglets
in this study developed arthritis. In humans [2] invasive
disease caused by S. pneumoniae mainly leads to meningi-
tis and sepsis. However, in humans S. pneumoniae can
also cause septic arthritis [3]. Although human pneumo-
coccal septic arthritis is less frequently observed it has
been described as an emerging problem [27]. So far, an
animal model inducing high levels of pneumococcal septic
arthritis was not available.
Pneumococcal septic arthritis is often accompanied by a
serum leukocytosis of > 11 × 109 cells liter−1. Systemically
Fig. 5 Playing behaviour of piglets during the experiment. Playing behaviour of piglets was measured in the intravenously infected piglets (panel
a) and the intranasally infected piglets (panel b) using a pedometer attached to a hanging chain. Read out gives an estimation of playing
behaviour for the whole group of piglets. Red line indicates the moment of infection. ● solid line indicates piglets infected with the high dose;
○ dashed line indicates piglets infected with the low dose
Fig. 6 Histological findings in joints of piglets inoculated with S. pneumoniae. Panels a and b were obtained from synovial membranes (SY) of
piglets inoculated intravenously with a high dose. Panel a: in joints with synovia hypersecretion typically few, small inflammatory foci with
perivascular mononuclear cells (arrow) were seen in the subsynovial tissue (SST); Panel b: serofibrinous arthritis with disruption of the synovial
membrane (SY) and extended inflammation of the subsynovial tissue (arrow) and the connective tissue (CT) of the joint capsule
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infected piglets also showed a serum leukocytosis, where
WBC counts > 34 × 109 cells liter−1 were observed. The
occurrence of arthritis after S. suis infection is very com-
mon in pigs, arthritis is often the first clinical symptom
that is observed [28]. The different outcome of clinical
disease caused by S. pneumoniae in humans and piglets
might be due to the species barrier. Experimental S.
pneumoniae models used doses ranging from 105 in hu-
man colonization studies [19, 29] to 2 × 106 in insects [30]
and 5 × 106 – 5 × 107 in rodent models [31–33]. In this
piglet model we used a dose of 2.5 × 106 CFU (low) and
2.9 × 108 CFU (high). The pneumococcal isolate used for
intravenous infection in this study was obtained from a
patient that suffered from pneumonia, meningitis and
sepsis. Apparently in piglets the pathogenesis have steered
towards arthritis, instead of to the development of menin-
gitis. However, it cannot be excluded that another human
pneumococcal isolate could also cause meningitis in pig-
lets, with or without arthritis.
Conclusion
Taken together, the data presented in the study demon-
strate that central aspects of human pneumococcal in-
fections can be modelled in piglets. Piglets can be very
useful hosts for studies on mechanisms of colonization
and invasive disease of S. pneumoniae infections as well
as on the development of improved pneumococcal vac-
cines. Moreover this is the first example of an animal




Twenty piglets (breed: Topigs 20) were purchased from a
pre-screened farm with a defined microbiological porcine
pathogen free status and were housed at the animal facil-
ities of the Central Veterinary Institute with ad libitum ac-
cess to water and feed. At the start of the experiment
tonsil swabs of piglets were screened for the presence of S.
suis. Animals negative for the most prevalent serotypes
were selected. After an acclimatization period of 7 days,
piglets were inoculated with S. pneumoniae at the age of
5 weeks, either intravenously (10 pigs) or intranasally (10
pigs), using two different doses. Intravenously inoculated
piglets were injected with 1 ml of PBS containing either
4.2 × 106 colony forming units (CFU) (low dose) or 2.9 ×
108 CFU (high dose) of S. pneumoniae strain PBCN214
into the vena jugularis. To establish colonization, piglets
were inoculated intranasally by using 3 ml of PBS contain-
ing either 2.5 × 106 CFU (low dose) or 2.9 × 108 CFU (high
dose) of S. pneumoniae BHN418 [29]. Therefore, aerosols
of the inocula were produced by a commercial, gravity-
fed, single trigger airbrush (Evolution™, Harder &
Steenbeek) with a nozzle of 0.2 millimeter, creating
an aerosol with about 10 % droplets which are smaller
than 26 micrometer and about 50 % of droplets which are
smaller than 50 micrometer in diameter.
Monitoring the health status
To monitor the health status of piglets, body tempera-
tures and clinical scores were systematically recorded 3
times a day, starting at 3 days before inoculation to rec-
ord baseline levels. Swelling of joints, particularly carpal,
tarsal and knee joints and occurring lameness were
assessed and interpreted as arthritis. Pigs were restraint
and blood was collected from the jugular vein on a daily
basis starting 3 days before inoculation to monitor white
blood cell counts (WBC), bacteraemia and to collect
plasma. WBCs were counted using an automated cell
counter (Sysmex, pocH-100iV-diff ), including differenti-
ation of blood cells.
Monitoring infection by cultivation, MALDI-TOF and PCR
analysis
Bacteraemia was monitored daily by plating 100 μl of
ethylenediaminetetraacetic acid (EDTA) blood directly
onto Columbia agar containing 5 % sheep blood and
5 μg ml−1 gentamycin. Plates were incubated for 16 h at
37 °C and colonies were counted. Bacteria isolated from
blood were confirmed to be S. pneumoniae using the
direct smear method on Bruker MALDI Biotyper Micro-
flex V.3.1, with the Bruker taxonomy database (4613 en-
tries). To obtain plasma, EDTA blood was centrifuged
for 15 min at 2500 × g. Plasma was stored at −20 °C for
subsequent analyses. Tonsil and nasal swabs were col-
lected daily, starting from day 0, to monitor colonization
of S. pneumoniae. Swabs were placed in 3 ml of sterile
PBS containing 15 % glycerol and sonicated in a water
bath (Ultrasonic Cleaner, VWR symphony) at room
temperature for 90 min. to elute bacteria from the
swabs. Subsequently, the material was stored at–20 °C
for subsequent analyses.
Necropsy
Animals were sacrificed at 7 days post-infection or when
pigs reached predefined humane end points. All piglets
were subjected to necropsy. During necropsy, samples
from the nasal mucosa, tonsils, lungs at 6 locations, in-
ternal organs (peritoneum, liver, kidney, spleen, thorax,
heart), and brain were taken for bacteriological examin-
ation. For this purpose, tissue was homogenized and serial
dilutions were plated for enumeration. Affected organs
were formalin fixed for histological examination. Formalin
fixed organ material was embedded in paraffin, sectioned
at 3 − 5 micrometer, and subsequently stained with
haematoxylin and eosin. Sections were microscopically
screened for pathological changes. Pro-inflammatory im-
mune responses were determined using commercial
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Quantikine ® Enzyme-Linked Immunosorbent Assay (ELISA)
kits for porcine Il-1-β and porcine IL-6 (R&D systems) ac-
cording to instructions of the manufacturer.
Quantification of pneumococcal DNA by qPCR
Pneumococcal DNA in tonsil and nasal swabs was deter-
mined by amplification of part of the autolysin (lytA) gene
using qPCR (lytA-Fw: 5′-ACGCAATCTAGCAGAT
GAAGCA-3′; lytA-Rev: 5′-TCGTGCGTTTTAATTC
CAGCT-3′). The 20 μl PCR mix consisted of 1× SsoAd-
vanced Universal SYBR Green Supermix (Biorad), 4 pmol
of each primer, and 1 μl of the extracted DNA. Thermal
cycling was performed in a CFX Real-time PCR system
(Biorad) under the following cycling conditions: 3 min at
95 °C, and 40 cycles of 10 sec at 95 °C and 30 sec at 55 °C.
A qPCR signal above 35 cycles was considered negative.
Additionally the qPCR mix contained 4 pmol of probe 5′-
(FAM)-GCCGAAAACGCTTGATACAGGGAG-(BHQI)-
3′ [34]. A standard curve of a ten-fold dilution series of
genomic DNA extracted from S. pneumoniae BHN418,
extracted with Qiagen columns and quantified with a
spectrophotometer (Nanodrop) was used to calculate the
amount of pneumococcal DNA per swab.
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